Welcome to CDC stacks | Precision Medicine Requires Precision Laboratories - 46689 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Precision Medicine Requires Precision Laboratories
  • Published Date:
    Jan 24 2017
  • Source:
    J Mol Diagn. 19(2):226-229.
Filetype[PDF-47.29 KB]


Details:
No Related Documents.
You May Also Like:
  1. CD4 Enumeration Technologies: A Systematic Review of Test Performance for Determining Eligibility for Antiretroviral Therapy
    Personal Author:
    Peeling, Rosanna W.; Sollis, Kimberly A.; Glover, Sarah; Crowe, Suzanne M.; Landay, Alan L.; Cheng, Ben; Barnett, David; Denny, Thomas N.; Spira, Thomas J.; Stevens, Wendy S.; Crowley, Siobhan; Essajee, Shaffiq; Vitoria, Marco; Ford, Nathan;
    Published:
    Mar 19 2015
    Source:
    PLoS One. 10(3).
    Description:
    Background : Measurement of CD4+ T-lymphocytes (CD4) is a crucial parameter in the management of HIV patients, particularly in determining eligibility to initiate antiretroviral treatment (ART). A number of technologies exist for CD4 enumeration, wit...
    File Type:
    Filetype[PDF - 1002.12 KB]
  2. Standardization of measurements of 25-Hydroxyvitamin D3 and D2
    Personal Author:
    Thienpont, Linda M.; Stepman, Hedwig C. M.; Vesper, Hubert W.;
    Published:
    2012
    Source:
    Scand J Clin Lab Invest Suppl. 243:41-49.
    Description:
    The vitamin D status is increasingly assessed/monitored in different populations, research cohorts and individual patients. This is done by measuring the liver metabolites 25-hydroxyvitamin D3 and D2 as biomarkers. Recommendations for using specific ...
    File Type:
    Filetype[PDF - 1.75 MB]
  3. Good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders
    Personal Author:
    Chen, Bin; Mei, Joanne; Kalman, Lisa; Shahangian, Shahram; Williams, Irene; Gagnon, MariBeth; Bosse, Diane; Ragin, Angela; Cuthbert, Carla; Zehnbauer, Barbara;
    Corporate Author:
    National Center for Environmental Health (U.S.). Division of Laboratory Sciences.. Centers for Disease Control and Prevention (U.S.). Office of Surveillance, Epidemiology, and Laboratory Services. Division of Laboratory Science and Standards.. National Center for Chronic Disease Prevention and Health Promotion (U.S.). Office on Smoking and Health..
    Published:
    April 6, 2012
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 61, no. 2
    Description:
    Biochemical genetic testing and newborn screening are essential laboratory services for the screening, detection, diagnosis, and monitoring of inborn errors of metabolism or inherited metabolic disorders. Under the Clinical Laboratory Improvement Ame...
    Status:
    current
    File Type:
    Filetype[PDF - 891.33 KB]
  4. One state's approach to the regulation of cholesterol screening.
    Personal Author:
    DeBoy, J M
    Published:
    1990 Nov-Dec
    Source:
    Public Health Rep. 105(6):584-588
    Description:
    In 1989 Maryland became the first State to enact legislation, separate from existing laboratory law, authorizing a comprehensive, self-supporting program to regulate cholesterol screening conducted outside of laboratories and physicians' offices. Thi...
    File Type:
    Filetype[PDF - 1019.29 KB]
  5. Good laboratory practices for molecular genetic testing for heritable diseases and conditions
    Personal Author:
    Chen, Bin; Gagnon, MariBeth C.; Shahangian, Shahram; Anderson, Nancy L.; Howerton, Devery A.; Boone, D. Joe;
    Corporate Author:
    National Center for Preparedness, Detection, and Control of Infectious Diseases (U.S.), Division of Laboratory Systems.. Centers for Disease Control and Prevention (U.S.).
    Published:
    July 12, 2009
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 58, no. RR-6
    Description:
    "Under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) regulations, laboratory testing is categorized as waived (from routine regulatory oversight) or nonwaived based on the complexity of the tests; tests of moderate and high complexity...
    File Type:
    Filetype[PDF - 593.10 KB]